Effect of RSR13 on temperature-dependent changes in hemoglobin oxygen affinity of human whole blood

Advances in Experimental Medicine and Biology

Volumn 454, Issue , 1998, Pages 653-661

  Steffen, Robert P ^a  

^a Allos Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; EFAPROXIRAL; HEMOGLOBIN; UNCLASSIFIED DRUG; ANILINE DERIVATIVE; ANTISICKLING AGENT; OXYGEN; OXYHEMOGLOBIN; PROPIONIC ACID DERIVATIVE;

BLOOD ANALYSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG BINDING; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPOXEMIA; MALE; NORMAL HUMAN; OXYGEN AFFINITY; OXYGEN DISSOCIATION CURVE; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; ARTICLE; BLOOD; DRUG EFFECT; IN VITRO STUDY; KINETICS; METABOLISM; TEMPERATURE; THERMODYNAMICS;

ANILINE COMPOUNDS; ANTISICKLING AGENTS; FEMALE; HEMOGLOBINS; HUMANS; KINETICS; MALE; OXYGEN; OXYHEMOGLOBINS; PROPIONIC ACIDS; TEMPERATURE; THERMODYNAMICS;

EID: 0032254103     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4863-8_77     Document Type: Article

References (24)

1. Abraham, D.J., Wireko, F.C., Randad, R.S., Poyart, C, Kister, J., and Bohn, B., 1992, Allosteric Modifiers of Hemoglobin: 2-[4-[[(3,5-Disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic Acid Derivatives That Lower the Oxygen Affinity of Hemoglobin in Red Cell Suspensions, in Whole Blood, and in vivo in Rats, Biochemistry, 31:9141-9149.
2. Teicher, B. A., Ara, G., Emi, Y., Kakeji, Y., Ikebe, M., Maehara, Y., and Buxton, D., 1996, RSR13: Effects on Tumor Oxygenation and Response to Therapy, Drug Development Research, 38:1-11.
3. 2 and Decreases Arteriolar Diameter and Flow in the Rat Cremaster Muscle, Microvascular Research, 52:58-68.
4. 2 Dissociation Curve, The Physiologist, 35(5):A-21.
5. Woods, J. A., Storey, C. J., Babcock, E. E., and Malloy, C. R., 1996, Cardioprotective Effects of a Synthetic Allosteric Modifier of Hemoglobin in Hyperkalemic Blood Cardioplegia , Proceedings of the International Society of magnetic Resonance in Medicine, 2:1023.
6. Entwistle, J.W.C., Crandall, J.D., and Wechsler, A.S., Enhanced myocardial performance and metabolism at low perfusion pressure with RSR13, an allosteric modifier of hemoglobin. Sponsored research on file at Allos Therapeutics.
7. Mejia, M. A., Gerstenblith, G., Chacko, V. P., diPaula, A.F., Becker, L. C., and Weiss, R. G., 1996, Preservation of High-energy Phosphates with an Allosteric Modifier of Hemoglobin-oxygen Affinity During Low-flow Ischemia in the Open-chest Dog, Circulation, 94 (Suppl I) 607.
8. Pagel, P.S., Hettrick, D.A., Montomery, M.W., Kersten, J.R., and Warltier, D.C., 1997, RSR13, A Novel Stabilizer of Deoxyhemoglobin, Enhances Recovery of Stunned Myocardium in Dogs, 1997. Oxygen Transport to Tissue XX Edited by A.G. Hudetz et. al. Plenum Press, New York, 1997.
9. Watson, J.C., Doppenberg, E.M.R., Bullock, M.R., Zauner, A., Rice, M.R., Abraham, D., and Young, H.F., 1997, Effects of the Allosteric Modification of Hemoglobin on Brain Oxygen and Infarct Size in a Feline Model of Stroke, Stroke, 28:1625-1631.
10. Oguma, F., Imai, S., Eguchi, S., 1986, Role played by oxygen in myocardial protection with crystalloid cardioplegic solution, Ann Thorac Surg, 41(2):172-9.
11. Vinten-Johansen, J., Julian, J.S., Yokoyama, H., et al., 1991, Efficacy of myocardial protection with hypothermie blood cardioplegia depends on oxygen, Ann Thorac Surg, 52 (4):939-48.
12. th Annual Meeting, AAPS, Seattle, WA, October 27-31, Pharm Res, 13 (9): S-479.
13. th Annual Meeting, AAPS, Seattle, WA, October 27-31, Pharm Res, 13 (9): S-115.
14. Mangano, D.T., 1995, Cardiovascular morbidity and CABG surgery - a perspective: epidemiology, costs, and potential therapeutic solutions, J Card Surg, 10:366-368.
15. Kuroda, Y., Uchimoto, R., Kaieda, R., et al., 1993, Central nervous system complications after cardiac surgery: a comparison between coronary artery bypass grafting and valve surgery, Anesth Analg, 76(2):222-7.
16. Shaw, P.J., Bates, D., Cartlidge, N.E., et al., 1987, Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery, Stroke, 18:700-7.
17. Roach, G.W., Kanchuger, M., Mora-Mangano, C., et al., 1996, Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med, 335(25):1857-63.
18. Clark, R.E., Brillman, J., Davis D.A., et al., 1995, Microemboli during coronary artery bypass grafting - genesis and effect on outcome, J Thorac Cardiovasc Surg, 109:249-58.
19. Smith, P.L., 1995, Cerebral dysfunction after cardiac surgery: closing address, Ann Thorac Surg, 59:1359-62.
20. Newman, M.F., Wolman, R., Kanchuger, M., et al., 1996, Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery, Circulation, 94[suppl II]:II-74-II-80.
21. Mora, C.T., Henson, M.B., Weintraub, W.S., et al., 1996, The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patients undergoing coronary revascularization, J Thorac Cardiovasc Surg, 112:514-22.
22. Croughwell, N., Lyth, M., Quill, T.J. et al., 1990, Diabetic patients have abnormal cerebral autoregulation during cardiopulmonary bypass, Circulation, 82 [suppl IV]:IV-407-IV-412.
23. Gold, J.P., Krieger, K.H., Isom, O.W., 1995, Improvement of outcomes after coronary artery bypass - a randomized trial comparing intraoperative high versus low mean arterial pressure, J Thorac Cardiovasc Surg, 110:1302-14.
24. Newman, M.F., Croughwell, N.D., Blumenthal, J.A., et al., 1996, Cardiopulmonary bypass and the central nervous system: potential for cerebral protection, J Clin Anesth, 8:53S-60S.